Brief: BioArctic Says CHMP Issues Positive Recommendation For Approval Of Lecanemab In The EU
14/11/2024 16:08
Nov 14 (Reuters) - BioArctic AB BIOAb.ST :
* CHMP ISSUES POSITIVE RECOMMENDATION FOR APPROVAL OF
LECANEMAB IN
THE EU
Source text: ID:nWkrcc0czS
Further company coverage: BIOAb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln